RadNet, Inc.

NasdaqGM:RDNT Stock Report

Market Cap: US$4.6b

RadNet Future Growth

Future criteria checks 4/6

RadNet is forecast to grow earnings and revenue by 70.6% and 12.7% per annum respectively. EPS is expected to grow by 74% per annum. Return on equity is forecast to be 5.9% in 3 years.

Key information

70.6%

Earnings growth rate

74.04%

EPS growth rate

Healthcare earnings growth18.5%
Revenue growth rate12.7%
Future return on equity5.90%
Analyst coverage

Good

Last updated01 May 2026

Recent future growth updates

Earnings Miss: RadNet, Inc. Missed EPS By 65% And Analysts Are Revising Their Forecasts

Nov 14
Earnings Miss: RadNet, Inc. Missed EPS By 65% And Analysts Are Revising Their Forecasts

RadNet, Inc. (NASDAQ:RDNT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 15
RadNet, Inc. (NASDAQ:RDNT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

RDNT: Sector Sentiment Tailwinds Will Support Future Earnings Visibility

Analysts have trimmed their price target on RadNet by $2 to reflect slightly updated assumptions on fair value, future P/E and operating metrics, while incorporating recent Street research that highlights improved sentiment following the Raymond James upgrade of Lumexa Imaging. Analyst Commentary Bullish Takeaways Bullish analysts view the recent upgrade of Lumexa Imaging as a supportive read-through for sentiment around diagnostic imaging.

RDNT: Outpatient Imaging Shift Will Support Future Earnings Visibility

RadNet's analyst price target now stands at $92. Analysts cite outpatient diagnostic imaging growth drivers, Medicare reimbursement support, potential capital deployment, and an AI ramp as key reasons for maintaining this level.

RDNT: Outpatient Imaging Shift And AI Adoption Will Drive Future Upside

Analysts kept their $92 price target for RadNet unchanged, citing what they see as attractive long term growth drivers in outpatient diagnostic imaging, reasonable 2025 to 2028 company targets, supportive Medicare reimbursement trends, potential capital deployment benefits, and expected AI contributions. Analyst Commentary Bullish Takeaways Bullish analysts view outpatient diagnostic imaging as an attractive subsector, with hospital to outpatient shifts and growing demand for advanced imaging seen as key growth drivers that support RadNet's long term story and current valuation framework.

RDNT: Outpatient Imaging Shift And AI Ramp Will Support Future Upside

Analysts have raised their price target on RadNet from $91.75 to $92.38. The updated target reflects revised assumptions that incorporate higher projected revenue growth, a lower profit margin outlook, and a higher future P/E multiple supported by recent bullish Street research on outpatient imaging and AI benefits.

RDNT: Outpatient Imaging Shift And AI Adoption Will Support Future Upside

Analysts have trimmed their implied future P/E assumption for RadNet, leading to a slightly lower blended price target of about $97 vs. roughly $102 previously.

RDNT: Outpatient Imaging Shift And AI Breast Screening Will Support Upside

Analysts have raised their price target on RadNet to about $92, reflecting confidence in the outpatient diagnostic imaging segment and the company's 2025 to 2028 targets, including expected benefits from improved Medicare rates, potential capital deployment, and increasing AI contributions. Analyst Commentary Recent research reflects a generally constructive tone on RadNet, with several firms lifting price targets into the high US$80s to low US$90s range and highlighting both the core imaging business and longer term AI potential.

RDNT: Outpatient Imaging Shift And AI Breast Screening Will Drive Upside

Analysts lifted their price target on RadNet to about US$91.75 from roughly US$91.71, reflecting recent coverage that highlights outpatient imaging growth drivers, supportive Medicare reimbursement, capital deployment options, and potential contributions from artificial intelligence (AI). Analyst Commentary Recent Street research on RadNet focuses on outpatient imaging growth, long term targets and the role of AI and capital allocation in supporting the current valuation framework.

RDNT: Outpatient Imaging And AI Adoption Will Drive Future Outperformance

Analysts have raised their price target on RadNet to about US$92, citing what they view as reasonable 2025 to 2028 goals, supportive Medicare reimbursement trends, potential capital deployment upside, and growing contributions from AI and outpatient imaging demand. Analyst Commentary Recent research has focused on how RadNet's outpatient imaging footprint, AI initiatives, and long term financial targets could support its valuation and growth ambitions.

RDNT: Integrated Offerings And Margin Expansion Will Drive Future Outperformance

Analysts have modestly increased their price target on RadNet, citing stronger long term growth and margin expansion prospects highlighted at the recent investor day and reflected in updated fair value estimates rising from about $91.71 to roughly $92.50 per share, alongside reaffirmed expectations for double digit revenue growth and mid teens EBITDA expansion. Analyst Commentary Bullish analysts highlight that the updated 2028 targets for double digit revenue growth and margin expansion underpin a durable mid teens EBITDA growth profile, which they view as supportive of further multiple expansion from current levels.

RDNT: Sustained Demand And Integrated Offerings Will Drive Future Outperformance

Analysts have raised their price target for RadNet from approximately $87 to $93, citing higher revenue growth expectations and confidence in the company’s integrated offerings and sustained demand. Analyst Commentary Bullish Takeaways Bullish analysts have raised price targets for RadNet, citing encouraging revenue growth expectations and confidence in the company’s ability to deliver sustained margin expansion.

Earnings Miss: RadNet, Inc. Missed EPS By 65% And Analysts Are Revising Their Forecasts

Nov 14
Earnings Miss: RadNet, Inc. Missed EPS By 65% And Analysts Are Revising Their Forecasts

RDNT: Momentum Will Accelerate From Surging Demand And Integrated Offerings

RadNet’s analyst price target has increased from $80.57 to $86.67. This reflects confidence from analysts who cite strong demand, integrated offerings, and positive industry momentum as key drivers.

RDNT: Imaging Center Demand And Digital Health Will Drive Measured Upside Potential

Analysts have increased their price target for RadNet from $74 to $81. They cite strong core imaging center demand and ongoing investments in digital health as key factors for the optimistic outlook.

AI Powered Imaging And Demographic Trends Will Accelerate Advanced Diagnostics

RadNet's analyst price target has been raised from $79.29 to $80.57 per share. This change reflects analysts' optimism amid strong imaging center demand, ongoing digital health investments, and potential M&A opportunities.

AI Powered Imaging And Demographic Trends Will Accelerate Advanced Diagnostics

RadNet’s consensus price target has risen to $79.29 as analysts cite robust imaging center demand, expanding service opportunities, strong digital health investments, and confidence in management’s strategic execution. Analyst Commentary Robust core imaging center demand trends indicate sustained growth potential.

RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

Sep 12
RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

AI Powered Imaging And Demographic Trends Will Accelerate Advanced Diagnostics

Driven by robust imaging center demand, growth opportunities, and strong digital health investments, RadNet’s consensus analyst price target held steady at $77.43. Analyst Commentary Robust core imaging center demand trends highlighted in recent management meetings.

RadNet: Bloated Capital Base Not Pulling Its Economic Weight (Rating Downgrade)

Aug 18

Some Confidence Is Lacking In RadNet, Inc.'s (NASDAQ:RDNT) P/S

Jul 31
Some Confidence Is Lacking In RadNet, Inc.'s (NASDAQ:RDNT) P/S

RadNet (NASDAQ:RDNT) May Have Issues Allocating Its Capital

Jul 15
RadNet (NASDAQ:RDNT) May Have Issues Allocating Its Capital

We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

Jun 10
We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

RadNet, Inc. (NASDAQ:RDNT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 15
RadNet, Inc. (NASDAQ:RDNT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Is There An Opportunity With RadNet, Inc.'s (NASDAQ:RDNT) 37% Undervaluation?

May 07
Is There An Opportunity With RadNet, Inc.'s (NASDAQ:RDNT) 37% Undervaluation?

Is RadNet, Inc. (NASDAQ:RDNT) Potentially Undervalued?

Apr 24
Is RadNet, Inc. (NASDAQ:RDNT) Potentially Undervalued?

Returns On Capital Signal Tricky Times Ahead For RadNet (NASDAQ:RDNT)

Apr 11
Returns On Capital Signal Tricky Times Ahead For RadNet (NASDAQ:RDNT)

RadNet: On The Sidelines For Now

Mar 11

There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Price

Feb 16
There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Price

A Look At The Fair Value Of RadNet, Inc. (NASDAQ:RDNT)

Jan 31
A Look At The Fair Value Of RadNet, Inc. (NASDAQ:RDNT)

Does RadNet (NASDAQ:RDNT) Have A Healthy Balance Sheet?

Jan 16
Does RadNet (NASDAQ:RDNT) Have A Healthy Balance Sheet?

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

Jan 01
Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Massive 26% Price Jump

Nov 12
There's Reason For Concern Over RadNet, Inc.'s (NASDAQ:RDNT) Massive 26% Price Jump

Here's What To Make Of RadNet's (NASDAQ:RDNT) Decelerating Rates Of Return

Oct 15
Here's What To Make Of RadNet's (NASDAQ:RDNT) Decelerating Rates Of Return

RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects

Oct 02

Unpleasant Surprises Could Be In Store For RadNet, Inc.'s (NASDAQ:RDNT) Shares

Sep 22
Unpleasant Surprises Could Be In Store For RadNet, Inc.'s (NASDAQ:RDNT) Shares
User avatar

Expanding Imaging Modalities And AI Integration Signal Strong Future Growth In Healthcare Sector

Expansion into advanced imaging and integration of AI technologies aim at boosting revenue through higher reimbursement rates and operational efficiencies.

RadNet: Growth In Operating Earnings Off Very Little Incremental Capital

Aug 24

RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly

Jul 22
RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly

Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

Jun 05
Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

RadNet: Qualified Growth Route, Still Undervalued

Jun 05

Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?

May 10
Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?

Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

Apr 08
Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues

Mar 06
RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues

Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching

Feb 08
Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching

RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation

Jan 28

Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult

Dec 28
Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult

We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt

Dec 04
We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt

RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively

Aug 27
RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively

RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

Aug 09
RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

Mar 30
We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends

Feb 19
RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends

Earnings and Revenue Growth Forecasts

NasdaqGM:RDNT - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20283,032791844574
12/31/20272,700741203235
12/31/20262,45432552436
12/31/20252,040-1986299N/A
9/30/20251,970-1352257N/A
6/30/20251,908-1576262N/A
3/31/20251,869-3278257N/A
12/31/20241,830345233N/A
9/30/20241,773-494279N/A
6/30/20241,7141068253N/A
3/31/20241,6582127205N/A
12/31/20231,617344221N/A
9/30/20231,580428186N/A
6/30/20231,528-1339181N/A
3/31/20231,479-1339178N/A
12/31/20221,4301127146N/A
9/30/20221,3828-11142N/A
6/30/20221,36523-5157N/A
3/31/20221,34418-27122N/A
12/31/20211,324256149N/A
9/30/20211,2973558164N/A
6/30/20211,2562477161N/A
3/31/20211,13811148221N/A
12/31/20201,098-15140234N/A
9/30/20201,090-10109192N/A
6/30/20201,091-13103191N/A
3/31/20201,164226118N/A
12/31/20191,1541530104N/A
9/30/20191,11133N/A111N/A
6/30/20191,06035N/A114N/A
3/31/20191,01536N/A119N/A
12/31/201897532N/A117N/A
9/30/2018953-4N/A154N/A
6/30/2018939-6N/A139N/A
3/31/2018925-6N/A136N/A
12/31/20179220N/A142N/A
9/30/201791211N/A112N/A
6/30/20179099N/A90N/A
3/31/20178977N/A102N/A
12/31/20168857N/A92N/A
9/30/20168755N/A82N/A
6/30/201685911N/A91N/A
3/31/201684511N/A71N/A
12/31/20158108N/A67N/A
9/30/201577911N/A67N/A
6/30/20157557N/A69N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RDNT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.5%).

Earnings vs Market: RDNT is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: RDNT is expected to become profitable in the next 3 years.

Revenue vs Market: RDNT's revenue (12.7% per year) is forecast to grow faster than the US market (11.2% per year).

High Growth Revenue: RDNT's revenue (12.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: RDNT's Return on Equity is forecast to be low in 3 years time (5.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/05 23:50
End of Day Share Price 2026/05/05 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

RadNet, Inc. is covered by 12 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sarah JamesBarclays
Andrew MokBarclays
Yuan ZhiB. Riley Securities, Inc.